Sleep Trackers and Health Screening: What FDA Clearance Actually Means

Consumer Devices Are Not Medical Devices

This guide explains the regulatory landscape around consumer sleep trackers and health screening. This is not medical advice. Any health concerns identified by a consumer device should be discussed with a healthcare provider.

Consumer sleep trackers are marketed as wellness devices, not medical devices. Most are regulated under the FDA's general wellness policy, which allows health-related claims as long as the device does not claim to diagnose, treat, or prevent disease. The distinction between wellness tracking and medical screening is both technical and regulatory.

What FDA 510(k) Clearance Means

The FDA 510(k) pathway allows a device to be marketed if it is "substantially equivalent" to a device already legally marketed. A 510(k) clearance means:

• The manufacturer submitted clinical or bench data demonstrating the device performs comparably to a predicate device
• The FDA reviewed the submission and agreed with the equivalence claim
• The device may be legally marketed for its cleared indication

A 510(k) clearance does not mean:

• The device has been independently validated by the FDA
• The device is approved (510(k) is "clearance," not "approval" -- these are different regulatory pathways)
• The device can diagnose conditions (screening and diagnosis are different)

Which Sleep Trackers Have FDA Clearance

Of the six major consumer sleep trackers, only two have FDA clearance for sleep-related screening:

Withings ScanWatch 2

FDA 510(k) clearance number: K201456 (October 2021)

The K201456 clearance covers ECG for atrial fibrillation detection and SpO2 (pulse oximetry) measurement. It is not a sleep-apnea-specific clearance. Withings markets the SpO2 feature as enabling detection of nighttime breathing disturbances, and the device analyzes overnight SpO2 patterns as part of its Sleep Apnea Alert feature, but the underlying 510(k) is for the ECG and SpO2 sensors themselves. The clearance is publicly documented in the FDA's 510(k) database.

Apple Watch Series 10

FDA-cleared for sleep apnea detection

Apple received FDA clearance for a sleep apnea notification feature that monitors breathing disturbances during sleep. The feature uses the accelerometer and other sensors to detect signs of sleep-disordered breathing.

Devices Without FDA Clearance

The Oura Ring Gen 3, Samsung Galaxy Ring, Fitbit Charge 6, and Whoop 4.0 do not have FDA clearance for any medical screening purpose. These devices track sleep and health metrics as wellness features, not as medical screening tools.

Screening vs. Diagnosis

This distinction is critical:

Screening identifies individuals who may have a condition and should seek further evaluation. A positive screening result is not a diagnosis. It is an indication that clinical evaluation is warranted. Consumer sleep trackers with FDA clearance are screening devices.

Diagnosis is a clinical determination made by a healthcare provider using validated diagnostic tools. For sleep apnea, diagnosis requires an in-lab polysomnography study or a home sleep apnea test (HSAT) prescribed and interpreted by a physician.

A consumer sleep tracker that flags possible sleep apnea is performing screening. The user should discuss the result with a healthcare provider, who will determine whether diagnostic testing is appropriate.

How Sleep Apnea Screening Works on Consumer Devices

FDA-cleared sleep apnea screening on consumer devices primarily uses one or both approaches:

SpO2-based detection. The device monitors blood oxygen levels during sleep using its SpO2 sensor. Obstructive sleep apnea causes repeated drops in blood oxygen (desaturations) as airway obstruction interrupts breathing. The device looks for patterns of desaturation that correlate with apnea events.

The Withings ScanWatch 2 uses this approach. Its SpO2 sensor runs continuously during sleep and analyzes the frequency and severity of desaturation events.

Motion-based detection. The device uses accelerometer data to detect breathing disturbances. Changes in chest/wrist movement patterns during apnea events create detectable motion signatures.

The Apple Watch uses this approach, analyzing motion patterns during sleep to identify signs of sleep-disordered breathing.

SpO2 Monitoring Without FDA Clearance

Several devices monitor SpO2 during sleep without FDA clearance for screening:

• Oura Ring Gen 3: Measures SpO2 overnight but does not claim to screen for sleep apnea
• Whoop 4.0: Measures SpO2 as part of its health metrics suite
• Fitbit Charge 6: Tracks SpO2 trends during sleep

These devices present SpO2 data as wellness information. They do not analyze the data for apnea patterns or make screening recommendations. The raw SpO2 data may be informative, but the devices do not interpret it in a clinical context.

The Samsung Galaxy Ring does not include an SpO2 sensor and cannot measure blood oxygen.

Limitations of Consumer Health Screening

Even FDA-cleared consumer screening has important limitations:

False positives. Consumer devices may flag normal variations as potential apnea. SpO2 can fluctuate due to sensor fit, position changes, or altitude, none of which indicate sleep apnea.

False negatives. No consumer screening device catches all cases. Mild sleep apnea with minimal desaturation may not trigger detection thresholds. A negative screening result does not rule out sleep apnea.

Population limitations. FDA clearance studies are conducted on specific populations. Performance may vary with age, skin tone (affecting SpO2 sensor accuracy), body composition, and medical conditions.

Not a replacement for clinical evaluation. If you have symptoms of sleep apnea (loud snoring, daytime sleepiness, witnessed breathing pauses), consult a healthcare provider regardless of what a consumer device reports.

Summary of Health Screening Capabilities

The following table shows FDA clearance status and health screening capabilities across all six devices reviewed.